SEMA3A and prostate carcinoma: SEMA3A is identified as a potent tumor suppressor in some cancers (breast cancer and prostate cancer [20,21]), inhibits endothelial cell adhesion and migration [22], induces the collapse of the actin cytoskeleton and apoptosis, reduces angiogenesis in vitro [23].